These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1336768)

  • 41. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
    Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
    J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calculating the social cost of illegal drugs: a theoretical approach.
    Diomidous M; Zimeras S; Mechili A
    Stud Health Technol Inform; 2013; 190():243-5. PubMed ID: 23823436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Structure and reimbursement in obstetrics - are births in level I perinatal centres economically sound?].
    Seelbach-Göbel B
    Z Geburtshilfe Neonatol; 2010 Oct; 214(5):198-204. PubMed ID: 21031329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Costing substance misuse services.
    Coyle D; Godfrey C; Hardman G; Raistrick D
    Addiction; 1997 Aug; 92(8):1007-15. PubMed ID: 9376770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mangement of drug problems in Hungary].
    Buda B
    Lege Artis Med; 2009 Sep; 19(8-9):537-41. PubMed ID: 20608432
    [No Abstract]   [Full Text] [Related]  

  • 46. Cost efficiency in primary care contracting: a stochastic frontier cost function approach.
    Puig-Junoy J; Ortún V
    Health Econ; 2004 Dec; 13(12):1149-65. PubMed ID: 15386681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do addiction services provide value for money?
    Godfrey G
    Addiction; 1994 Aug; 89(8):915-7; discussion 919-23. PubMed ID: 7950850
    [No Abstract]   [Full Text] [Related]  

  • 48. Understanding clinical complexity in delinquent youth: comorbidities, service utilization, cost, and outcomes.
    Hussey DL; Drinkard AM; Falletta L; Flannery DJ
    J Psychoactive Drugs; 2008 Mar; 40(1):85-95. PubMed ID: 18472668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of alternative staff time data collection methods on drug treatment service cost estimates.
    Zarkin GA; Dunlap LJ; Wedehase B; Cowell AJ
    Eval Program Plann; 2008 Nov; 31(4):427-35. PubMed ID: 18640722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The social and economic consequences of epilepsy: a controlled national study.
    Jennum P; Gyllenborg J; Kjellberg J
    Epilepsia; 2011 May; 52(5):949-56. PubMed ID: 21275976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Why we should still estimate the costs of substance abuse even if we needn't pay undue attention to the bottom line.
    Single E
    Drug Alcohol Rev; 2009 Mar; 28(2):117-21. PubMed ID: 19320695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The economic costs of heroin addiction in the United States.
    Mark TL; Woody GE; Juday T; Kleber HD
    Drug Alcohol Depend; 2001 Jan; 61(2):195-206. PubMed ID: 11137285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical fallacy and treatment outcomes.
    Gossop M
    Addiction; 2008 Jan; 103(1):89-90. PubMed ID: 18081613
    [No Abstract]   [Full Text] [Related]  

  • 56. The effectiveness of drug treatment.
    Gerstein DR
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
    [No Abstract]   [Full Text] [Related]  

  • 57. Unit cost of counseling and patients length of stay in a residential drug treatment setting.
    Alemi F; Haack M; Holifield L; Claudio Y; Haqqi K
    J Ment Health Policy Econ; 2002 Sep; 5(3):103-7. PubMed ID: 12728196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The economic costs of illicit drug use in Ontario, 1992.
    Xie X; Rehrn J; Single E; Robson L; Paul J
    Health Econ; 1998 Feb; 7(1):81-5. PubMed ID: 9541086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Out-of-pocket cost of drug abuse consequences: results from Iranian National Mental Health Survey.
    Amin-Esmaeili M; Hefazi M; Radgoodarzi R; Motevalian A; Sharifi V; Hajebi A; Rahimi-Movaghar A
    East Mediterr Health J; 2017 May; 23(3):150-160. PubMed ID: 28493261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimating the costs of substance abuse: implications to the estimation of the costs and benefits of gambling.
    Single E
    J Gambl Stud; 2003; 19(2):215-33. PubMed ID: 12766470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.